Scientists discover a therapeutic target for Alzheimer’s disease

Scientists at Université Laval and the University of Lethbridge have succeeded in reversing certain cognitive manifestations associated with Alzheimer’s disease in an animal model of the disease.

ADA Advises Against Compounded GLP-1s; Growth Hormone Therapy Guide; T1D Outcomes Up

The American Diabetes Association (ADA) urged healthcare providers against prescribing non-FDA approved compounded GLP-1 and dual GIP/GIP-1 receptor agonists for type 2 diabetes or obesity

December 4, 2024

Apollo secures funds to advance pipeline programmes

Share this article Since its founding, Apollo Therapeutics secured total funds of more than $450m. Credit: Gorodenkoff / Shutterstock.com. Apollo Therapeutics has secured $33.5m in

January 2, 2024

AstronauTx wins £48m in funding for developing Alzheimer’s therapies – Pharmaceutical Technology

GlobalData forecasts the Alzheimer’s market to generate $13.7bn in sales across the eight major markets. Image Credit: Berit Kessler / Shutterstock. British biotech AstronauTx has

October 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.